quinazolines has been researched along with Fibroma, Shope in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bossart, W; Etter, A; Fehr, T; Hässig, A; Müller, N; Roos, M; Schiesser, M; Wüthrich, RP | 1 |
Bégin, LR; Bourque, G; Caron, M; Deblois, G; Giguère, V; Gravel, SP; Labbé, DP; Muller, WJ; Park, M; Savage, P; Smith, HW; St-Pierre, J; Tam, IS; Tremblay, ML | 1 |
Flanagan, N; Howett, MK; Moyer, J; Neely, EB; Parkinson, T; Patrick, SD; Perros, M; Pollack, VA; Pustilnik, LR; Welsh, PA | 1 |
3 other study(ies) available for quinazolines and Fibroma, Shope
Article | Year |
---|---|
Association of BK viremia with human leukocyte antigen mismatches and acute rejection, but not with type of calcineurin inhibitor.
Topics: Adult; Aged; Allografts; Antibodies, Monoclonal; Azathioprine; Basiliximab; BK Virus; Cohort Studies; Cyclosporine; Female; Glomerular Filtration Rate; Graft Rejection; Histocompatibility; HLA Antigens; Humans; Immunosuppressive Agents; Kidney Diseases; Kidney Transplantation; Logistic Models; Male; Middle Aged; Multivariate Analysis; Mycophenolic Acid; Polyomavirus Infections; Proteinuria; Pyrroles; Quinazolines; Recombinant Fusion Proteins; Tacrolimus; Tumor Virus Infections; Viremia | 2014 |
ERRα mediates metabolic adaptations driving lapatinib resistance in breast cancer.
Topics: Animals; Antineoplastic Agents; Breast Neoplasms; Cell Survival; Drug Resistance, Neoplasm; ERRalpha Estrogen-Related Receptor; Humans; Lapatinib; Mammary Neoplasms, Experimental; Mammary Tumor Virus, Mouse; MCF-7 Cells; Mice; Quinazolines; Receptor, ErbB-2; Receptors, Estrogen; Retroviridae Infections; Signal Transduction; TOR Serine-Threonine Kinases; Tumor Virus Infections | 2016 |
An inhibitor of the epidermal growth factor receptor function does not affect the ability of human papillomavirus 11 to form warts in the xenografted immunodeficient mouse model.
Topics: Administration, Oral; Administration, Topical; Animals; Disease Models, Animal; Enzyme Inhibitors; ErbB Receptors; Female; Human papillomavirus 11; Humans; Immunocompromised Host; Mice; Mice, Inbred BALB C; Mice, Nude; Quinazolines; Transplantation, Heterologous; Tumor Virus Infections; Virus Replication; Warts | 2007 |